191 results
S-8
EX-23.2
KPRX
Kiora Pharmaceuticals Inc
10 May 24
Registration of securities for employees
6:59am
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement
S-8
EX-23.1
KPRX
Kiora Pharmaceuticals Inc
10 May 24
Registration of securities for employees
6:59am
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement
424B3
KPRX
Kiora Pharmaceuticals Inc
28 Mar 24
Prospectus supplement
4:48pm
then ended, have been audited by Haskell & White LLP, independent registered public accounting firm, as stated in their report dated March 25, 2024, which … audited by EisnerAmper LLP, independent registered public accounting firm, as stated in their report dated March 23, 2023, which is incorporated herein
8-K
EX-10.1
knperlcjsofgy5t3t
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-4.2
nftrxjr
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-4.1
vnivjbc
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-4.3
wcwaekre
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-99.1
wmc7aqb0vnuj22q2lzb8
31 Jan 24
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-10.1
ygmh i7t1jgwh
31 Jan 24
Entry into a Material Definitive Agreement
5:14pm
S-8
7d9rq1z
13 Oct 23
Registration of securities for employees
5:09pm
S-8
EX-23.1
8thlxkza
13 Oct 23
Registration of securities for employees
5:09pm
8-K
fkgvjsmjraqx3
1 Aug 23
Biotech Leader Carmine Stengone Joins Kiora Pharmaceuticals' Board of Directors
7:00am